Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
203.30 EUR | 0.00% | +4.77% | +27.49% |
Sep. 13 | Safran: contract to supply PASEO sighting system | CF |
Sep. 12 | RBC Capital Begins Safran Coverage at Outperform | MT |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 25.1B | 16.63B | 15.13B | 19.52B | 23.65B | |||||
Other Revenues, Total | 166M | 149M | 160M | 151M | - | |||||
Total Revenues | 25.26B | 16.78B | 15.29B | 19.67B | 23.65B | |||||
Cost of Goods Sold, Total | 13.48B | 8.91B | 7.66B | 10.27B | 12.44B | |||||
Gross Profit | 11.79B | 7.87B | 7.64B | 9.4B | 11.21B | |||||
Selling General & Admin Expenses, Total | 6.36B | 5.1B | 5B | 5.88B | 6.98B | |||||
Provision for Bad Debts | -4M | 83M | 15M | 25M | 5M | |||||
Depreciation & Amortization - (IS) | 1.6B | 1.21B | 1.51B | 1.17B | 1.28B | |||||
Other Operating Expenses | 131M | 51M | -135M | -127M | -240M | |||||
Other Operating Expenses, Total | 8.09B | 6.45B | 6.39B | 6.96B | 8.03B | |||||
Operating Income | 3.7B | 1.42B | 1.25B | 2.45B | 3.18B | |||||
Interest Expense, Total | -81M | -80M | -102M | -88M | -119M | |||||
Interest And Investment Income | 51M | 24M | 19M | 45M | 237M | |||||
Net Interest Expenses | -30M | -56M | -83M | -43M | 118M | |||||
Income (Loss) On Equity Invest. | 164M | 48M | 40M | 73M | 99M | |||||
Currency Exchange Gains (Loss) | -283M | -257M | -497M | -5.07B | 1.85B | |||||
Other Non Operating Income (Expenses) | -37M | -37M | -11M | 10M | -7M | |||||
EBT, Excl. Unusual Items | 3.51B | 1.12B | 695M | -2.58B | 5.24B | |||||
Restructuring Charges | - | -182M | -79M | - | -45M | |||||
Merger & Related Restructuring Charges | -25M | - | - | -13M | -24M | |||||
Impairment of Goodwill | - | - | - | -319M | -327M | |||||
Gain (Loss) On Sale Of Investments | -5M | -4M | -3M | -54M | 14M | |||||
Gain (Loss) On Sale Of Assets | -15M | -7M | -17M | -37M | - | |||||
Asset Writedown | -42M | -303M | -161M | -119M | -36M | |||||
Other Unusual Items | 49M | -50M | -167M | 6M | -67M | |||||
EBT, Incl. Unusual Items | 3.47B | 570M | 268M | -3.12B | 4.76B | |||||
Income Tax Expense | 962M | 184M | 200M | -694M | 1.24B | |||||
Earnings From Continuing Operations | 2.51B | 386M | 68M | -2.43B | 3.52B | |||||
Earnings Of Discontinued Operations | - | - | - | - | - | |||||
Net Income to Company | 2.51B | 386M | 68M | -2.43B | 3.52B | |||||
Minority Interest | -65M | -34M | -25M | -33M | -76M | |||||
Net Income - (IS) | 2.45B | 352M | 43M | -2.46B | 3.44B | |||||
Net Income to Common Incl Extra Items | 2.45B | 352M | 43M | -2.46B | 3.44B | |||||
Net Income to Common Excl. Extra Items | 2.45B | 352M | 43M | -2.46B | 3.44B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 5.69 | 0.83 | 0.1 | -5.76 | 8.24 | |||||
Basic EPS - Continuing Operations | 5.69 | 0.83 | 0.1 | -5.76 | 8.24 | |||||
Basic Weighted Average Shares Outstanding | 430M | 426M | 427M | 427M | 418M | |||||
Net EPS - Diluted | 5.63 | 0.8 | 0.1 | -5.76 | 8.07 | |||||
Diluted EPS - Continuing Operations | 5.63 | 0.8 | 0.1 | -5.76 | 8.07 | |||||
Diluted Weighted Average Shares Outstanding | 435M | 440M | 440M | 427M | 431M | |||||
Normalized Basic EPS | 4.96 | 1.56 | 0.96 | -3.86 | 7.66 | |||||
Normalized Diluted EPS | 4.9 | 1.51 | 0.93 | -3.86 | 7.42 | |||||
Dividend Per Share | - | 0.43 | 0.5 | 1.35 | 2.2 | |||||
Payout Ratio | 32.08 | - | 425.58 | -8.66 | 16.38 | |||||
American Depositary Receipts Ratio (ADR) | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | |||||
Supplemental Items | ||||||||||
EBITDA | 5.05B | 2.75B | 2.52B | 3.75B | 4.41B | |||||
EBITA | 4.43B | 2.15B | 1.92B | 2.45B | 3.18B | |||||
EBIT | 3.7B | 1.42B | 1.25B | 2.45B | 3.18B | |||||
EBITDAR | - | 2.82B | 2.6B | 3.83B | 4.61B | |||||
Total Revenues (As Reported) | 25.4B | 16.9B | 15.51B | 19.96B | 24.12B | |||||
Effective Tax Rate - (Ratio) | 27.69 | 32.28 | 74.63 | 22.24 | 25.99 | |||||
Total Current Taxes | 1.1B | 278M | 379M | 585M | 928M | |||||
Total Deferred Taxes | -133M | -94M | -179M | -1.28B | 308M | |||||
Normalized Net Income | 2.13B | 664M | 409M | -1.65B | 3.2B | |||||
Interest Capitalized | 8M | 8M | 5M | 5M | 4M | |||||
Interest on Long-Term Debt | 10M | 8M | 13M | 14M | 14M | |||||
Non-Cash Pension Expense | 18M | 4M | -6M | 2M | 9M | |||||
Supplemental Operating Expense Items | ||||||||||
Research And Development Expense From Footnotes | 1.32B | 905M | 997M | 977M | 1.42B | |||||
Net Rental Expense, Total | - | 68M | 79M | 85M | 198M | |||||
Imputed Operating Lease Interest Expense | - | 6.68M | 9.53M | 8.95M | 28.71M | |||||
Imputed Operating Lease Depreciation | - | 61.32M | 69.47M | 76.05M | 169M | |||||
Stock-Based Comp., SG&A Exp. (Total) | 49M | 10M | 25M | 32.9M | 64.2M | |||||
Stock-Based Comp., Other (Total) | - | 5M | - | - | - | |||||
Total Stock-Based Compensation | 49M | 15M | 25M | 32.9M | 64.2M |